CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity

被引:4
|
作者
Ando, Yayoi [1 ,2 ]
Maeshima, Akiko Miyagi [1 ]
Fukuhara, Suguru [2 ]
Makita, Shinichi [2 ]
Munakata, Wataru [2 ]
Suzuki, Tatsuya [2 ]
Maruyama, Dai [2 ]
Taniguchi, Hirokazu [1 ]
Izutsu, Koji [2 ]
机构
[1] Natl Canc Ctr, Div Pathol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Dept Hematol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
关键词
CD3; CD56; Epstein-Barr virus; Nasal cavity; Plasmacytoma; EPSTEIN-BARR-VIRUS; PLASMABLASTIC LYMPHOMA; SOLITARY PLASMACYTOMA; IMMUNOCOMPETENT; DIAGNOSIS; NEOPLASMS; FEATURES; TUMORS;
D O I
10.1007/s12185-018-2438-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present a case of atypical extraosseous plasmacytoma (EP) with a plasmablastic morphology and CD3(+) CD56(+) Epstein-Barr virus-encoded RNA-1 (EBER1)(+) phenotypes of the nasal cavity. A 51-year-old male attended a local hospital with a tumor located in his left nasal cavity that was histologically diagnosed as extranodal NK/T cell lymphoma, nasal type. We reviewed the specimens and re-biopsied the tumor, and confirmed that the tumor was positive for CD3, CD56, and EBER1; however, the tumor showed a plasmablastic morphology without necrosis and angiocentricity, and was positive for CD138, but negative for CD20 and PAX5. Given a plasmablastic morphology and EBER1 positivity, but a relatively low Ki67 index (30%), we diagnosed the case as atypical EP. The CHOP regimen was administered and complete remission achieved. This case indicated that EP should be considered as a differential diagnosis even when a tumor shows large cell morphology and is positive for CD3, CD56, and EBER1.
引用
收藏
页码:344 / 347
页数:4
相关论文
共 50 条
  • [1] CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity
    Yayoi Ando
    Akiko Miyagi Maeshima
    Suguru Fukuhara
    Shinichi Makita
    Wataru Munakata
    Tatsuya Suzuki
    Dai Maruyama
    Hirokazu Taniguchi
    Koji Izutsu
    International Journal of Hematology, 2018, 108 : 344 - 347
  • [2] Modulation of INK receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and INKT-like (CD3+/CD56+) cells in coronary artery disease
    Aguilar, P
    Clerc, G
    Mathieu, CP
    Fajraoul, M
    Popovic, B
    Aliot, E
    Faure, GC
    Bene, MC
    Ethevenot, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 330A - 330A
  • [3] Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation
    Aguilar, P
    Mathieu, CP
    Clerc, G
    Ethevenot, G
    Fajraoui, M
    Mattei, S
    Faure, GC
    Bene, MC
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : 200 - 205
  • [4] In vitro studies of the role of CD3+ and CD56+ cells in fetal liver cell alloreactivity
    Lindton, B
    Markling, L
    Ringdén, O
    Westgren, M
    TRANSPLANTATION, 2003, 76 (01) : 204 - 209
  • [5] Non nasal CD3- CD56+ lymphoma: A clinicopathologic study of 3 cases
    Lepretre, S
    Dubruille, V
    Lemee, L
    Lenormand, B
    Lenain, P
    Stamatoullas, A
    Buchonnet, G
    Callat, MP
    Joly, P
    Tilly, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 122 - 122
  • [6] The Function of CD3+ CD56+ NKT-Like Cells in HIV-Infected Individuals
    Jiang, Yongjun
    Cui, Xiaojian
    Cui, Chen
    Zhang, Jian
    Zhou, Fangyuan
    Zhang, Zining
    Fu, Yajing
    Xu, Junjie
    Chu, Zhenxing
    Liu, Jing
    Han, Xiaoxu
    Liao, Christina
    Wang, Yanan
    Cao, Yaming
    Shang, Hong
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [7] CD3+ CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis
    Koreck, A
    Surányi, A
    Szöny, BJ
    Farkas, A
    Bata-Csörgö, Z
    Kemény, L
    Dobozy, A
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (01): : 176 - 182
  • [8] Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/TCRγδ+) and DERL-7 (CD56+/CD3−/TCRγδ−), derived from a single patient with CD56+ non-Hodgkin's lymphoma
    R Di Noto
    F Pane
    A Camera
    L Luciano
    M Barone
    C Lo Pardo
    P Boccuni
    M Intrieri
    B Izzo
    MR Villa
    M Macrí
    B Rotoli
    L Sacchetti
    F Salvatore
    L Del Vecchio
    Leukemia, 2001, 15 : 1641 - 1649
  • [9] CD56+ CD3+ T cells in relation to infection in normal subjects and kidney transplant patients
    Almehmadi, M.
    Hammad, A.
    Howarth, S.
    Flangan, B. R.
    Christmas, S. T.
    IMMUNOLOGY, 2012, 137 : 398 - 398
  • [10] Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/TCRγδ+) and DERL-7 (CD56+/CD3-/TCRγδ-), derived from a single patient with CD56+ non-Hodgkin's lymphoma
    Di Noto, R
    Pane, F
    Camera, A
    Luciano, L
    Barone, M
    Lo Pardo, C
    Boccuni, P
    Intrieri, M
    Izzo, B
    Villa, MR
    Macrí, M
    Rotoli, B
    Sacchetti, L
    Salvatore, F
    Del Vecchio, L
    LEUKEMIA, 2001, 15 (10) : 1641 - 1649